Infinity Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Infinity Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2023-03-28
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $5.20M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.50M.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-28 |
| 2021-12-31 | $5.20M 10-K · filed 2022-03-29 |
| 2020-12-31 | $3.50M 10-K · filed 2021-03-16 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-03 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2017-12-31 | $200.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-14 |
| 2015-12-31 | $2.30M 10-K · filed 2016-02-23 |
| 2014-12-31 | $31.10M 10-K · filed 2015-02-24 |
| 2013-12-31 | $18.90M 10-K · filed 2014-02-25 |
| 2012-12-31 | $90.40M 10-K · filed 2013-03-05 |